Can Fite Biopharma Ltd ADR Long-term Investment Intensity
Can Fite Biopharma Ltd ADR long-term investment intensity. Can Fite Biopharma Ltd ADR (CANF) has a Long-term Investment Intensity of 9.9% as of September 2018. Long-term investments of $1.08 Million represent 9.9% of total assets of $10.82 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read total liabilities of Can Fite Biopharma Ltd ADR for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Can Fite Biopharma Ltd ADR (2017–2017)
Long-term investment intensity of Can Fite Biopharma Ltd ADR from 2017 to 2017. This chart shows how Can Fite Biopharma Ltd ADR's Long-term Investment Intensity has evolved across 1 annual periods from 2017 to 2017. As of September 2018, the intensity stands at 9.9%, reflecting long-term investments of $1.08 Million against total assets of $10.82 Million USD.
Can Fite Biopharma Ltd ADR Long-term Investment Intensity by Year (2017–2017)
Can Fite Biopharma Ltd ADR long-term investment intensity by year from 2017 to 2017. The table below presents the year-by-year Long-term Investment Intensity for Can Fite Biopharma Ltd ADR from 2017 to 2017, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Can Fite Biopharma Ltd ADR's balance sheet.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2017 | 11.7% | $914.66K | $7.83 Million | — |